Psoriasis Awareness Month – August 2024

Psoriasis Awareness Month 2024 Glint Lab


August is the time to highlight the latest advances in understanding and treating psoriasis, a chronic skin condition that speeds up the growth of skin cells, leading to thick, red, scaly patches. This debilitating disease affects nearly 125 million people globally, including 8 million Americans, significantly impacting their quality of life and presenting considerable management challenges.

At GlintLab, we support scientists and researchers in the early discovery and preclinical stages by offering advanced histopathology services to enhance the understanding and treatment of inflammatory and autoimmune diseases.

Recent research has introduced new treatment options, including biologic drugs, JAK inhibitors, gene therapy, and novel topical treatments. The National Psoriasis Foundation, Mayo Clinic, and Cleveland Clinic provide support and information to patients and are good resources for everyone to learn more about this debilitating condition. The good news is that more than 250 pharmaceutical companies and research organizations have been working on finding better solutions and new treatments for Psoriasis, with about 70 of them having at least one on-going clinical trial such as UCB, Abbvie, Bausch Health Americas, Sun Pharma, Janssen, BI, and BMS to name a few. For a comprehensive list of clinical trials, feel free to download the data we collected from the National Library of Medicine


At GlintLab, we can help with Psoriasis research by leveraging our innovative research services:

Partner with us to advance your research in psoriasis and other inflammatory and autoimmune diseases.



Discover more from Glint Lab Website

Subscribe now to keep reading and get access to the full archive.

Continue reading